Oric Pharmaceuticals (ORIC) Research & Development (2019 - 2026)
Oric Pharmaceuticals (ORIC) reported Research & Development of $36.3 million for Q2 2026, up 18.8% from $30.55 million a year earlier and up 15.5% from the prior quarter.
Powered by 
Analysis
Oric Pharmaceuticals (ORIC) Research & Development (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Oric Pharmaceuticals' Research & Development came in at $122.36 million, up 3.4% year-over-year; for FY2025, it came in at $109.82 million, down 3.7% from FY2024.
- Research & Development has a five-year compound annual growth rate of 25.0% (FY2020 to FY2025).
- By year, Research & Development came in at $114.07 million in FY2024 (+33.9%), $85.17 million in FY2023 (+38.1%), $61.68 million in FY2022 (+8.5%) and $56.86 million in FY2021 (+58.3%).
- The Q2 2026 figure ranks as the highest quarterly Research & Development in data going back to Q1 2019.
- Year over year, Research & Development gained in six of the last eight quarters, with growth averaging 13.4%.
- The high point for year-over-year Research & Development in five years was Q2 2024 (growth of 54.0%); the low point was Q4 2025 (a decline of 19.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $31.44 million (Q1 2026), $25.86 million (Q4 2025) and $28.77 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Oric Pharmaceuticals | 1.38 Bn | 1.38 Bn | - | 36.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36.30 Mn |
| Mar 31, 2026 | 31.44 Mn |
| Dec 31, 2025 | 25.86 Mn |
| Sep 30, 2025 | 28.77 Mn |
| Jun 30, 2025 | 30.55 Mn |
| Mar 31, 2025 | 24.64 Mn |
| Dec 31, 2024 | 31.97 Mn |
| Sep 30, 2024 | 31.20 Mn |
| Jun 30, 2024 | 28.94 Mn |
| Mar 31, 2024 | 21.96 Mn |
| Dec 31, 2023 | 24.48 Mn |
| Sep 30, 2023 | 22.39 Mn |
| Jun 30, 2023 | 18.79 Mn |
| Mar 31, 2023 | 19.52 Mn |
| Dec 31, 2022 | 16.30 Mn |
| Sep 30, 2022 | 14.72 Mn |
| Jun 30, 2022 | 13.83 Mn |
| Mar 31, 2022 | 16.83 Mn |
| Dec 31, 2021 | 16.75 Mn |
| Sep 30, 2021 | 12.90 Mn |
API Access
Oric Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ORIC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ORIC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ORIC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();